US 10214498
Heterocyclic compound
granted A61KA61K31/415A61K31/421
Quick answer
US patent 10214498 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/415, A61K31/421, A61K31/4418, A61K31/505